Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab

A 43-year-old woman with a history of recently diagnosed metastatic melanoma was commenced on systemic therapy with nivolumab, an anti-programmed cell death-1 monoclonal antibody and one of an increasing group of the so-called ‘immune checkpoint inhibitors’. She experienced a dramatic complete respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Matthew JS, Roberts, Mark E, Lorigan, Paul C, du Plessis, Daniel G, Chinoy, Hector
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836669/
https://www.ncbi.nlm.nih.gov/pubmed/29437773
http://dx.doi.org/10.1136/bcr-2017-223249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836669/
https://www.ncbi.nlm.nih.gov/pubmed/29437773
http://dx.doi.org/10.1136/bcr-2017-223249

Ejemplares similares